Attached files
| file | filename |
|---|---|
| 10-K - TG THERAPEUTICS, INC. | v216358_10k.htm |
| EX-31.2 - TG THERAPEUTICS, INC. | v216358_ex31-2.htm |
| EX-23.1 - TG THERAPEUTICS, INC. | v216358_ex23-1.htm |
| EX-31.1 - TG THERAPEUTICS, INC. | v216358_ex31-1.htm |
Exhibit 32.1
CERTIFICATION
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of Manhattan Pharmaceuticals, Inc. hereby certifies that, to the best of his knowledge:
(a) the Annual Report on Form 10-K of Manhattan Pharmaceuticals, Inc. for the year ended December 31, 2010 the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(b) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Manhattan Pharmaceuticals, Inc.
|
Dated: March 31, 2011
|
/s/ Michael McGuinness
|
|
|
|
Michael G. McGuinness
|
|
|
|
Principal Executive Officer,
|
|
|
|
Chief Operating and Financial Officer
|